INDmoney
HRMY
Harmony Biosciences Holdings Inc Earnings
$36.03
Earnings Summary
Revenue | $239.46Mn |
Net Profits | $50.87Mn |
Net Profit Margins | 21.24% |
Harmony Biosciences Holdings Inc’s revenue jumped 28.71% since last year same period to $239.46Mn in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 19.44% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit jumped 10.35% since last year same period to $50.87Mn in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 27.88% jump in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin fell -14.26% since last year same period to 21.24% in the Q3 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 7.07% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.85 |
EPS Estimate Current Year | 0.85 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.85 - a -0.99% fall from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.85.
Key Ratios
Earning Per Share (EPS) | 0 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Harmony Biosciences Holdings Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-05 | 0.85 | 0 | -100% |
